The World of Health & Medicine News

Chew On This: Scientists Create Gum That Traps Herpes, Flu Viruses

Chew On This: Scientists Create Gum That Traps Herpes, Flu Viruses

The battle against common viral infections might soon include an unexpected weapon: chewing gum. Researchers at the University of Pennsylvania have created a specialized gum that could trap and neutralize herpes and influenza viruses before they spread or cause infection.

A plant-based chewing gum made from lablab beans can trap and neutralize flu and herpes viruses in the lab, offering a potential new way to reduce transmission directly in the mouth, where these viruses often spread.

The antiviral protein in the gum (FRIL) stays stable for over two years at room temperature, making it a promising option for global use without the need for refrigeration or injections.

Though results so far are limited to lab tests, the gum has passed safety checks and is now approved for clinical trials, which will help determine whether it actually prevents infection in people./ Molecular Therapy

spot_img

Explore more

spot_img

Vaccine group Gavi seeks to broaden donor base as aid budgets...

Vaccine group Gavi seeks to broaden donor base as aid budgets shrink   Global vaccine group Gavi is seeking new donors for its work funding childhood...

Novavax’s COVID-flu combo vaccine shows strong immune response in trial

Novavax's COVID-flu combo vaccine shows strong immune response in trial Novavax's (NVAX.O), opens new tab experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response...

Regeneron’s weight-loss drug helps patients on Wegovy preserve muscle

Regeneron's weight-loss drug helps patients on Wegovy preserve muscle Regeneron (REGN.O), opens new tab said on Monday its experimental drug helped patients preserve up to 51% of...

Surge in new opioids and designer drugs threatens Europe, EU drug...

Surge in new opioids and designer drugs threatens Europe, EU drug agency warns Massive shipments of previously unknown recreational designer drugs and potent new opioids...

AI-Designed Drugs Expected to Enter the Market by the End of...

AI-Designed Drugs Expected to Enter the Market by the End of the Decade A pharmaceutical startup has announced that the first drugs fully designed using...

Insmed’s drug for rare lung disease achieves ‘home run’ in mid-stage...

Insmed's drug for rare lung disease achieves 'home run' in mid-stage trial  Insmed (INSM.O), opens new tab said on Tuesday that its experimental drug significantly reduced blood...

US FDA approves Merck’s RSV antibody for infants

US FDA approves Merck's RSV antibody for infants The U.S. Food and Drug Administration on Monday approved Merck's (MRK.N), opens new tab preventive antibody shot to protect...

Novo Nordisk starts new CagriSema weightloss drug trial

Novo Nordisk starts new CagriSema weightloss drug trial Novo Nordisk (NOVOb.CO), opens new tab has launched a new late-stage trial for its experimental next-generation obesity drug...